Screening for anti-cancer agents against the smoothened receptor using novel mass spectrometry-based methodology
Screening for anti-cancer agents against the smoothened receptor using novel mass spectrometry-based methodology
批准号:
2748015
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background The smoothened receptor is an integral transmembrane protein that forms a key component of the so-called hedgehog cell-cell signalling pathway. Mutations in the smoothened protein can lead to overactivation of the pathway, which results in cell proliferation and cancer, including medulloblastoma, basal-cell carcinoma and pancreatic cancer. The drug vismodegib, which targets smoothened, is FDA-approved for use against basal-cell carcinoma, and is currently in trials against other cancers, but the emergence of vismodegib-resistant smoothened mutants makes the search for alternatives a high priority. This project centres on the development and of a novel screening platform and its application to the discovery of smoothened inhibitors.Methodology and Experimental Approaches We have shown that photochemical carbene footprinting is a powerful method for mapping protein binding sites (Nat. Commun. 2016, Angew. Chem. Int Ed. 2017, Nat. Chem. Biol. 2018, Nat. Chem. 2019, Proteomics 2021). The method uses differential labelling with a footprinting probe in the presence and absence of a binding partner (protein or small molecule) to show where masking of the protein surface occurs and hence identify the binding site. The DTP student develop a novel screening platform by using differential labelling of a reporter peptide in the smoothened binding site to inform the presence of a bound ligand (Fig 1). A reference peptide will provide a control for labelling efficiency.Research-based training The Oldham group provides an excellent environment for interdisciplinary research and training, with a strong collaborative ethos. Current joint projects with colleagues in the Schools of Chemistry (Soultanas, Hayes), Life Sciences (Layfield) and Biosciences (Holdsworth) illustrate the breadth of collaboration. As part of their research project, the student will gain key skills in the handling and characterisation of membrane proteins (see training from non-academic partner for expression and purification training). A key tool in the protein footprinting methodology is the application of mass spectrometry for mapping the sites of protein modification, and reporting binding in the screen. The student will receive high-level training in protein mass spectrometry, including MALDI-MS, LC-MS and MS/MS to enable them to conduct the footprinting project. These are transferable skills for protein identification and PTM characterisation, and are thus highly sought-after generally. Data handling and interpretation is crucial to footprinting methodology. The CASE student will be instructed in how to extract information from the raw MS data and judge its significance through the application of statistical analysis. The student will receive health and safety training through the School of Chemistry's induction sessions. These are enabled throughout the year by use of video lectures, supporting documents, and online resources. Specific health and safety training for the mass spectrometry lab is provided by the academic supervisor, as is a set of SOPs for each instrument and technique in the lab.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:程瑶
-
依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
-
批准号:JCZRQN202500319
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:仇凤启
-
依托单位:
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究
-
批准号:2025JJ80620
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘钰
-
依托单位:
Anti-MDA5阳性皮肌炎病人的NK细胞数量与功能改变在间质性肺疾病中的作用与机制研究
-
批准号:MS25H100014
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:韩咏梅
-
依托单位:
特发性膜性肾病血清标志物anti-PLA2R-IgG4检测方法的建立及临床应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:徐燕
-
依托单位:
CCL2介导PGK1的O-GlcNAc糖基化修饰诱导CAFs代谢重编程促进头颈癌anti-PD-1免疫治疗耐药的机制研究
-
批准号:
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:苑振楠
-
依托单位:
经 anti-GPC3 修饰的外泌体靶向递送索拉非尼与放疗联合诱
导肝细胞癌铁死亡的研究
-
批准号:2024JJ9608
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:段和新
-
依托单位:
千金藤素通过自噬损伤导致的免疫原性细胞死亡促进 anti-PD1 治疗MSS 型结直肠癌的疗效与机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:赵明
-
依托单位:
周细胞 ZEB1/SPP1 旁分泌轴招募 MDSCs 诱导
卵巢癌 anti-PD1/PD-L1 疗法耐药的机制研究
-
批准号:Y24H310009
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:程溥
-
依托单位: